
Lessons Learned From the 2025 International Stroke Conference: Keith Churchwell, MD, FAHA, FACC, FACP
The president of the American Heart Association provided post-conference commentary on the advances shaping stroke care and excitement behind this year’s International Stroke Conference. [WATCH TIME: 3 minutes]
"Fast forward to 2025, and what was once science fiction in stroke care is now reality—it’s truly remarkable."
This year’s
ISC 2025 also featured over 10 late-breaking trials, focusing on areas like expanded time windows for thrombolysis, novel adjunctive therapies for thrombectomy, and enhanced post-stroke recovery protocols. While some of these trials were considered “negative” for their results, they will be critical in shaping the future of stroke care and research, Keith Churchwell, MD, FAHA, FACC, FACP, told NeurologyLive®.
Churchwell, president of the American Heart Association (AHA), sat down to discuss some of the main takeaways from the meeting, highlighting the exciting research and innovative ideas being brought to the table. In the discussion, he spoke on the progress made over the decades, emphasizing the contrast between the limited stroke treatments available earlier in his career and the remarkable innovations of today. Churchwell, who most recently served as president of Yale New Haven Hospital and associate clinical professor of medicine at
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.